Academician profile · PROFESÖR
MEHMET SÖNMEZ
- TIP FAKÜLTESİ
- DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
Scopus (SJR)
Q1
40
Q2
67
Q3
75
Q4
20
WoS (JCR)
Q1
13
Q2
19
Q3
55
Q4
111
TR Index
49
articles
Articles
- 2025 Clinical Manifestations, Treatment Characteristics and Clinical Outcome in Patients with Acquired Thrombotic Thrombocytopenic Purpura (aTTP) in the Real-World Setting: An Interim Analysis of the Turkish aTTP Registry
- 2025 Retrospective Evaluation of the Incidence, Clinical Characteristics and Outcomes of Gram-Negative Bacterial Infections in Patients with Hematologic Malignancies
- 2025 Involvement of PERK and ATF6 signal pathways in indicating unfolded protein response in patients with chronic lymphocytic leukaemia
- 2024 Management of Adult Primary Immune Thrombocytopenia: Delphi- Based Consensus Recommendations
- 2024 Pyruvate kinase deficiency in 29 Turkish patients with two novel intronic variants
- 2024 Management of Primary Immune Thrombocytopenia – Turkish Modified Delphi-Based Consensus Statement for Special Considerations
- 2023 Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial
- 2023 EE554 Cost-Effectiveness Analysis of Novoseven® Treatment for Postpartum Hemorrhage in Turkiye
- 2023 International Forum: The Turkish perspective on apheresis activity: The Turkish apheresis registry report
- 2023 Glofitamab in relapsed/refractory diffuse large B‐cell lymphoma: Real‐world data
- 2023 Polatuzumab vedotin, rituximab, and bendamustine combination in relapsed or refractory diffuse large B-cell lymphoma: a real-world data from Turkey
- 2022 Effect of Clinical, Endoscopic, Radiological Findings, and Complications on Survival in Patients with Primary Gastrointestinal Lymphoma
- 2022 Patient characteristics and management practices in chronic myeloid leukemia in Turkey: reflections from an expert meeting
- 2022 Endothelial Progenitor Cell Levels and Extent of Postprandial Lipemic Response
- 2022 The Effect of Comorbidities on the Choice of Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia
- 2022 Turkey Real-Life Data: Demographic Features, Treatment Results and Effects of Comorbidities in Chronic Myeloid Leukemia
- 2022 Çoklu İlaca Dirençli Akut Graft Versus Host Hastalığında Ruksolitinib
- 2022 Cytotoxic effects of water and ethanolic extracts of Turkish propolis on human laryngeal epidermoid carcinoma cell lines
- 2021 Efficacy and safety of ruxolitinib in patients with myelofibrosis: a retrospective and multicenter experience in Turkey
- 2021 Brentuximab vedotin consolidation therapy after autologous stem\u2010cell transplantation in patients with high\u2010risk Hodgkin lymphoma: Multicenter retrospective study